key: cord-1010319-f9ic9pnm
authors: Shi, Ruona; Feng, Zhenhuan; Zhang, Xiaofei
title: Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses
date: 2021-11-10
journal: Genomics Proteomics Bioinformatics
DOI: 10.1016/j.gpb.2021.09.007
sha: 20d43d8386f68c25e88bb593b7cd0cb09826dd47
doc_id: 1010319
cord_uid: f9ic9pnm

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently a global pandemic. Extensive investigations have been performed to study the clinical and cellular effects of SARS-CoV-2 infection. Mass spectrometry-based proteomics studies have revealed the cellular changes due to the infection and identified a plethora of interactors for all SARS-CoV-2 components, except for the longest non-structural protein 3 (NSP3). Here, we expressed the full-length NSP3 proteins of SARS-CoV and SARS-CoV-2 to investigate their unique and shared functions using multi-omics methods. We conducted interactome, phosphoproteome, ubiquitylome, transcriptome, and proteome analyses of NSP3-expressing cells. We found that NSP3 plays essential roles in cellular functions such as RNA metabolism and immune response such as NF-κB signal transduction. Interestingly, we showed that SARS-CoV-2 NSP3 has both endoplasmic reticulum and mitochondrial localizations. In addition, SARS-CoV-2 NSP3 is more closely related to mitochondrial ribosomal proteins, whereas SARS-CoV NSP3 is related to the cytosolic ribosomal proteins. In summary, our integrative multi-omics study of NSP3 improves the understanding of the functions of NSP3 and offers potential targets for the development of anti-SARS strategies.

326 infection of A549 cells.

Our proteomics (interactome, phosphoproteome, and ubiquitylome) analysis identified the 328 significant enrichment of proteins related to mRNA splicing. Therefore, we performed the 329 alternative splicing analyses of our transcriptome results. We observed 381 and 514 alternative 330 splicing events in CoV2-NSP3-and CoV1-NSP3-expressing cells, respectively (Figure 7C and 331 Table S7 ). Among them, a large portion of altered splicing events was detected on the exon cassette 332 and intron retention region, indicating that NSP3 proteins alter host cell RNA processing.

Further, we performed FASP-based proteome analysis of NSP3-expressing cells in parallel.

334 Differentially expressed proteins (DEPs) were calculated with thresholds of FDR < 0.05, and 335 |L2FC| > 1 ( Figure 7D and Table S8 ). Among them, we found that a known target of CoV1-NSP3, Figure 7D and 340 Table S8 ). A comparison of transcriptome and proteome data revealed that NF-κB2 was 341 upregulated at both levels, indicating a positive feedback regulation, and highlighting the pivotal 342 roles of NSP3 in NF-κB signaling ( Figure 7E ).

344 Multi-omics reveal cellular events regulated by NSP3 and the potential repurposing of drugs 345 We combined all our significant candidates to systematic analysis CoV2-NSP3 regulated cellular 346 events. We included known protein-protein interactions and regulation events to expand the 347 connections of our candidates. Among the many cellular events we found, TP53 was one of the 348 proteins that was extensively regulated by NSP3 ( Figure 8A ). We found interactors, activators, 349 and inhibitors of TP53 in our multi-omics studies. In addition, these regulators were associated 350 with other candidates, further expanding the diffusion network. Therefore, we concluded that 351 NSP3 attacks p53 at multiple levels to circumvent the antiviral defense effects of p53 [44, 46] .

352 Furthermore, the innate immune response, a surveillance system that SARS-CoV-2 needs to evade 358 these data imply that NSP3 has diverse cellular effects in SARS-CoV-2 infection.

Finally, we analyzed our data to identify proteins that were significantly enriched in at least 360 two omics studies of NSP3 expressing cells ( Figure 8C and Table S9 ). In the meantime, we 361 searched these candidate proteins against the drug database drugbank (https://go.drugbank.com/).

In total, 13 proteins were regulated by NSP3 proteins, and two (JAK1 and PPP2CA) out of them 363 had 9 FDA-approved drugs ( 

a multi-omics study (interactome, phosphoproteome, ubiquitylome, transcriptome) on

We first analyzed the interactome of NSP3 using Flag-178 immunoprecipitation coupled with mass spectrometry identification. As shown in Figure S5A, 179 principal component analysis (PCA) of the top 1000 variable proteins showed a strong correlation 180 within the triplicate experiments for NSP3 proteins. In addition, the interactome of the WT and 181 CS mutants of NSP3 showed a good correlation, implying that the catalytic activity has minor 182 effects on the NSP3 interactome

Next, we compared these two NSP3 interactomes side by side to 185 study their shared and specific interactions (Figure 3A and Table S1). We noticed that RCHY1, a 186 known interactor of the macrodomain and PLpro of NSP3

However, the overall similarities between the two NSP3 interactomes was low (55 out of 382

Gene ontology (GO) and Reactome [30] analyses of significant 189 interactors highlighted the roles of both NSP3 proteins in RNA splicing, NF-κB signaling, and the 190 regulation of translation (Figures 3B, S5C, and S5D, Table S1). The most striking difference 191 between the two interactomes was that CoV2-NSP3 was linked to mitochondrial translation, 192 whereas CoV1-NSP3 was associated with cytosolic translation. We verified a few specific and 193 shared interactions using immunoprecipitation followed by immunoblotting (Figure 3C). For 194 example, TAB2 and TAB3 showed similar binding ability to both NSP3 proteins, whereas 195 cytosolic ribosomal proteins and mitochondria ribosomal proteins

To avoid missing of transient protein-protein interactions and to identify a core protein-protein 198 interaction complex, we repeated our interactome study using a crosslinking method

D and Table S2) called rapid immunoprecipitation mass spectrometry of endogenous proteins

Strikingly, most of the interactors of CoV2-NSP3 were mitochondrial proteins 203 including mitochondrial ribosomal protein large subunits (MRPLs), mitochondrial ribosomal 204 protein small subunits (MRPSs), and coenzyme Q (COQs) (Figure S6C). In addition, biological 205 process (BP) analysis showed that proteins that related to the mitochondrial gene expression

As shown in Figure S7B, RCHY1 was again enriched with both NSP3 212 proteins again. The overall similarities between the two EGFP interactomes was a slightly higher 213 than those of Flag-IP (27% vs. 15%, Figures S5B and S7C). Consistent with immunostaining 214 results using EGFP antibody, interactors of both NSP3 proteins were related to the ER (Figure 215 S7D and Table S3). In addition

With the 68 NSP3 interacting 221 proteins that were found in at least two previous studies, 26 out of them were identified in our 222 studies (Figure 3D and Table S3). Importantly, interactors that have higher identification 223 frequency in previous studies had a better chance to be identified in our studies (Figure 3E), 224 indicating that interactome based on full-length NSP3 is more reliable. Therefore, 346 specific 225 interactors for full-length

To study how the NSP3 protein is connected to other SARS-CoV-2 proteins and host proteins, we 229 mined our data with reported SARS-CoV-2 interactors

Here, we combined all our 230 identified NSP3 interactors with reported interactors for all other SARS-CoV-2 proteins. As shown 231 in Figure 4 and Table S4, NSP3 was linked to multiple viral proteins via its interacting partners, 232 suggesting that they work coordinately to regulate host cell functions. We found that NSP3, ORF3, 233 and NSP6 shared multiple ER-localized interactors

ER-localization of both NSP3 proteins. Furthermore, both NSP3 proteins were linked to NSP6 via 235 ATP metabolism-related proteins. Interestingly, only CoV2-NSP3 was associated with NSP8 and 236 M proteins via mitochondrial-related proteins

addition, ORF7A almost exclusively interacted with CoV2-NSP3, but not CoV1

These results indicated that NSP3 coordinates with other viral proteins to regulate cellular 239 functions

Taken together, our interactome results indicated the following: 1) regulation of RNA 241 metabolism could be the main function of NSP3; 2) both NSP3 proteins are associated with protein 242 translation but employ different translation machinery; 3) The N-terminus of CoV2-NSP3 243 determines the interaction with mitochondria

We validated the serine and threonine 255 phosphorylation of UBE2O and TNIP1 using immunoprecipitation followed by immunoblotting 256 (Figure 5B). BP and Reactome analyses of NSP3 shared DEPPs (Figure 5A and Figure 5C, cluster 257 5 and 6) showed that terms related RNA metabolism, the regulation of viral transcription, and 258 potential therapeutics for SARS were enriched with both NSP3 proteins. Interestingly, similar BP 259 and Reactome terms were found for DEPPs in cluster 2 and cluster 4, although they were specific 260 DEPPs for CoV2-NSP2 and CoV1-NSP3, respectively. To dissect the contributions of NSP3 to 261 the host cell phosphoproteome during viral infection, we compared our results with recently 262 reported SARS-CoV-2 phosphoproteome datasets

We found that the altered activity of CDK4, 269 CK1, TBK1, and DYRK2 was conserved in both NSP3-expressing cell lines. However, the 270 activities of multiple CDKs were upregulated in CoV1-NSP3-expressing cells, whereas only 271 CDK4 activity was upregulated in CoV2-NSP3-expressing cells. The decrease of CDK2

As CDKs play an important role in cell cycle progression, we showed that the expression of 274 both NSP3 proteins caused a prolonged G2 phase compared to that of control cells (Figure S8C)

We retrieved 12 kinases and 18 kinase inhibitors from our 277 phosphoproteome data of CoV2-NSP3-expressing cells, whereas 7 kinases and 13 kinase 278 inhibitors were found for CoV1-NSP3-expressing cells. Further, one of the inhibitors, fostamatinib, 279 a treatment for chronic immune thrombocytopenia targeting multiple mapped kinase pathways 280

Interestingly, we noticed that the interferon activators, IKK-family and TBK1 kinases were 282 significantly present in CoV1-NSP3-expressing cells (Figure S8E and S8F)

Ubiquitination is used by both viruses and host cells to combat each other

We used the antibody-based K--GG peptide enrichment method to 289 study the effects of WT and CS-mutated NSP3 on the ubiquitylome of the host cells. Because the 290 levels of ISGylation and neddylation are relatively low in cells

We noticed that most of the ubiquitination events, except some 295 in cluster 1, 4, and 8, were not consistent in NSP3-expressing cells. However, GO analysis showed 296 similar enriched terms, such as positive regulation of viral life cycle, mRNA splicing, cell cycle 297 regulation, and translation initiation, for both NSP3 proteins (Figure 6B). These results indicated 298 that two NSP3 proteins have similar cellular functions, although they might function through 299 different substrates

This observation suggested that the marked effects of NSP3 on the cellular ubiquitylome is 302 catalytic activity-independent, which was also observed for other deubiquitinases

We next mapped all ubiquitinate sites of NSP3 proteins to their functional domains and found 304 that the overall ubiquitination sites were conserved in both NSP3 proteins (Table S6). The three 305 domains, HVR, Ubl2, and TM/3Ecto, had almost no ubiquitinated sites, explained by the fact that 306 these domains only have a few lysine residues

CoV1-NSP3 had three ubiquitinated sites, whereas no such ubiquitination was observed in CoV2-308 NSP3 (Figure 6C). However, these three lysine amino acids were also conserved in CoV2-NSP3 309 (Figure 6D), raising questions about why the N-terminus of NSP3 proteins is differently 310 ubiquitinated, and as well as the mechanisms underlying and consequences of these differences

Transcriptome and proteome changes in NSP3-expressing cells

We also measured the transcriptome and proteome of control and NSP3-expressing cells using 314 deep-sequencing and filter-aided sample preparation (FASP)-based proteomics analyses. As 315 shown in Figure 7A, differentially expressed genes (DEGs) were calculated using thresholds of

Using motif enrichment analysis, we found that RELB-, NF-B1-, and NF-κB2-318 binding motifs were highly represented in the upregulated DEGs

We then matched our gene lists with C2 (chemical and genetic perturbations sub-collection) and

As shown in Figure 7B and Table S7, our upregulated genes 323 were correlated with multiple reported gene sets, and a large portion of them was related to In summary, we expressed and studied the localization of NSP3 proteins. We identified a rich 418 candidate resource for studying the functions of NSP3 proteins and provided a systematic analysis 419 of how NSP3 contributes to the regulation of cellular function. Importantly, we showed that 420 although both NSP3 proteins shared extensive similar functions, SARS-CoV-2 NSP3 is different 421 from SARS-CoV NSP3 in its connection with mitochondrial proteins. Moreover

Plasmids, cell culture, transfection, immunoblotting and immunoprecipitation

Full-length coding sequences of SARS-CoV-1 and SARS-CoV-2 NSP3 (FJ882960 and

MN988669, without codon optimization) with earlier inserted stop codon were synthesized from

Polymerase Chain Reaction (PCR) amplified products were 430 subcloned into homemade lentivirus vector either with C terminal EGFP or N-terminal Flag and 431 C-terminal EGFP tags. Mutagenesis PCR was performed to mutate the earlier stop codon to 432 generate wild type NSP3 using Phanta Max Super-Fidelity DNA polymerase

The same method was used to create catalytic inactivated (CS mutated), glygly 434 deficient (dGG), and domain exchanged NSP3 plasmids

TNIP cDNA was amplified from HeLa cDNA and cloned in to pCS2 vector with Flag 436 tag

HEK293T cells from ATCC (American Type Culture Collection) were cultured in Dulbecco's

with 10% fetal 440 bovine serum (FBS, SV30160.03, Cytiva, Boston, MA) and 1 × penicillin/streptomycin 441 (SV30010-10, Cytiva). HEK293T cells were tested mycoplasma free using MycoAlert Detection 442 Kit

PA) with a ratio of plasmids: PEI = 1:3. Cells were harvest using whole cell lysate 445 buffer (0.5% NP-40, 150 mM NaCl, 50 mM Tris

Equivalent amounts of 449 proteins were boiled with 1  LDS loading buffer (NP0008, Thermo) for 5 min at 95ºC and 450 resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. For 451 immunoprecipitation, Flag-M2 agarose beads (A2220, Sigma) were used to enrich NSP3 and 452 interactors. For phosphorylation validation, 1 × PhosSTOP (4906837001, Sigma) was added to 453 lysis buffer, and immunoprecipitation was performed either with Flag agarose beads for 2 h or 454 with 1 g UBE2O antibody (A301-873A, Bethyl, Montgomery, AL) overnight following with 15 455 μL prewashed protein A/G beads (1:1 mixture, 1614013 and 1614023

NSP3 (ab181620, Abcam, Cambridge, 459 UK), UBE2O (A301-873A, Bethyl), pSerine (gtx26639

TAB2 (A302-759A, Bethyl), TAB3 (A302-208A, Bethyl), RPL5 461 (A303-933A, Bethyl), RPS6 (A300-556A, Bethyl)

MRPL23 (11706-1-AP, Proteintech), MRPL44 (16394-1-AP, Proteintech)

DHX38 (A300-858A-T, Bethyl), IPO4 (11679-1-AP, Proteintech), IPO11(14403-1-AP, 464 Proteintech), NUP85 (19370-1-AP, Proteintech), and GAPDH-HRP

Cells grown on 0.1% gelatin coated coverslips were transfected with indicated plasmid for 36 h

Sigma) and blocked with 10% FBS. Indicated first 472 antibody and second antibody were added for overnight at 4ºC and 1 h at room temperature, 473 respectively. Cells were mounted with ProLong Gold Antifade Reagent with DAPI

Images were taken and processed using LSM800 and LSM900

Antibodies used for the experiment are: CANX (2679

Cell cycle and mitochondrial potential experiments were performed using FACS. For cell cycle 480 analysis, approximately 1mL of 1  10 6 /mL cells transfected with indicated plasmids were harvest 481 and fixed with 70% ethanol (1.00983.1011, Sigma) overnight. 0.1% Triton-X100 was used to 482 permeabilize cells before the staining with propidium iodide (P4864, Sigma) for 15 min at room 483 temperature

HEK293T cell transfected with indicated plasmids in biological triplicates were lysed using whole 487 cell lysis buffer (50 mM Tris pH 8.0 (15504020, Thermo), 150 mM NaCl

20 min at room temperature 493 first, then replaced with 1% formaldehyde (F8775, Sigma) for 10 min at room temperature, 494 followed with quenching with 0.1 M glycine for another 10 min at room temperature. Cells were 495 incubated for 2 h at 4ºC on a rotation wheel. Soluble cell lysates were collected after maximum 496 speed centrifugation at 4ºC for 15 min

Sigma) or GFP (gtma, Chromotek, Planegg-Martinsried, Germany) magnetic agarose for 1

On-bead digestion was performed to digest immunoprecipitated protein to peptides for mass 499 spectrometry (MS) measurements [54]. In short, beads after incubation were washed 3 times with 500 cell lysis buffer and 1 time with Phosphate buffered saline (PBS, C10010500BT, Thermo)

10 mM DTT (dithiothreitol, D9779, Sigma), and 50 mM Tris with pH 8.5) for

Sigma) was added to a final concentration of 50 mM for 504 10 min in the dark, following with 250 ng of trypsin (V5280, Promega, Madison, WI) partially 505 digestion for 2 h. After incubation, the supernatant was collected into a separate tube. The beads 506 were then incubated with 100 μL of elution buffer for another 5 min, and the supernatant was 507 collected in the same tube. All these steps were performed at room temperature in a thermoshaker 508 C at 1500 rpm. Combined elutes were digested with additional 200 ng of trypsin overnight at room 509 temperature. Finally

Sigma) buffer (4% SDC, 100 mM Tris, and pH 8.5) and 515 phosphoproteome sample preparation was performed according to previous report [34]. In brief, 516 200 g of cell lysates were reduced and alkylated with Tris (2-carboxyethyl) phosphine 517 hydrochloride (TCEP, 75268, Sigma) and 2-chloroacetamide

) were used to 520 enrich phosphorylated peptide and homemade C8 (66882-U, Sigma)

TiO 2 beads for washes. Eluted phosphorylated peptides were loaded into homemade SDB-RPS

HEK293T cell transfected with indicated plasmids in biological triplicates were lysed using buffer 526 containing 8 M urea, 50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM EDTA

CAA, and 1  Complete Protease inhibitors. K--GG ubiquitin Remnant Motif enrichment kit from

Cell Signaling) was used to enrich K--GG peptides. The whole process was 529 performed according to the manufacturer's instruction except in the steps of digestion and peptide 530 desalting. We used Lys-C to digest 3 mg protein in 8 M urea buffer for 3 h at 37ºC first, and then 531 diluted to 2 M urea and trypsinization overnight at 37ºC

Elute LRC-C18 200 mg column from Agilent

Soluble cell lysates were collected after 10 538 cycles of sonication for 30 s followed by 30 s at 4ºC using a

Belgium), followed with maximum speed centrifugation at room temperature for 15 min

Whole proteome peptides were prepared using the FASP protocol as described before [54]. In brief, 541 50 μg of soluble lysates was added onto 30 kDa cutoff filter (MRCF0R030, Sigma) and centrifuged 542 at 11,000 rpm at 20ºC for 15 min. 50 mM IAA in urea buffer was used to alkylate proteins at 20ºC

Sigma) buffer, 500 ng of trypsin in 50 μL 50 mM ABC buffer was 545 used to digest proteins in a wet chamber overnight at 37ºC. Peptides was extracted by 50 mM ABC

HEK293T cell transfected with indicated plasmids in biological triplicates were harvested and total 550 RNA was isolated using ipureTRizol kit according to manufacturer's instruction (K417, IGEbio)

Sequencing libraries were generated using Next UltraTM RNA Library Prep Kit for Illumina 552 (E7760, NEB, Ipswich, UK) following manufacturer's recommendations. In brief, mRNA was 553 captured using mRNA capture beads, followed with fragmentation and cDNA synthesize using 554 random hexamers. DNA clean beads was used to purified dsDNA after the second strand synthesis

Sequencing was done by Illumina NovaSeq platform (IGEbio)

Thermo) mass spectrometer 561 equipped with FAIMS pro (high-Field Asymmetric waveform Ion Mobility Spectrometry, Thermo) 562 using different gradient of buffer B (80% acetonitrile (1000041001, Sigma) and 0.1% formic acid 563 (1002641000, Sigma)). For interactome study, a gradient of total 140 min of 100 min 2% to 22%, 564 20 min 22% to 28%, 12 min 28% to 36%, and 8 min 100% of buffer B was used; for proteome and 565 ubiquitylome analysis, a gradient of total 240 min of 1 min of 2%, 10 min 2% to 7%, 200 min 7% 566 to 28%, 15 min 28% to 36%, 5 min 36% to 60%, and 7 min 95% of buffer B was used; for 567 phosphoproteome analysis, a gradient of total 120 min of 80 min 2% to 22%, 20 min 22% to 28%, 568 12 min 28% to 40%, and 8 min 95% of buffer B was used. Data dependent analysis was used as 569 data acquisition mode. Detailed information about the gradient and the setting of the MS can be 570 found in the raw files (PXD023927)

PCA for all omics studies were performed using top 1000 variable events with maximum standard 579 deviation of NSP3-expressing cells

We filtered out the protein that labelled as reverse or potential contaminant, and 585 analyzed the non-crosslinking interactome and proteome data using DEPs [56]. The significant 586 thresholds were L2FC > 2, FDR < 0.001 for interactome, and |L2FC| > 1, FDR < 0.05 for proteome 587 analyses. For crosslinking interactome analysis, we used an alternative method described before

we used a cutoff line with the function y > c / (x -x 0 ) on scatters 590 where x is the L2FC and y is adjusted P value (c = curvature, x 0 = minimum fold change). The 591 distribution of L2FC between NSP3 overexpression and EGFP control were fitted to a Gaussian 592 curve using least squares fitting (excluding outliers) to determine the standard deviation σ. We set rate

Protein-protein interaction (PPI) network and pathway annotation of interactors was 597 constructed by Cytoscape plugin ReactomeFI v7.2.3 [58]. Interactors of NSP3 were divided into 598 3 groups (CoV1, CoV2, and both) and enriched GO terms were shown using clusterProfiler

Phospho(STY)sites" was used for testing intensity 603 differences of phosphosites between control and NSP3 expressing cells. We performed Student's 604 t test as two-sample-test and one-way analysis of variance (ANOVA) test following Tukey's 605 significant honest difference post-hoc test (THSD) as multiple-sample-test. P values were adjusted 606 by Benjamini & Hochberg (BH) method

To study change of kinase activities, we ranked phosphosites by L2FC

KSEA) using KSEAapp package [61] in combination with a 610 reported kinase-substrate relationship [62]. We filtered out the kinases of which matching sites 611 was less than 3 or Z-score was lower than 1 and created human kinome tree illustration using

The ubiquitylome data was analyzed as described for phosphoproteome. Here, we defined peptide 617 with adjusted P < 0.001, |L2FC| > 2, and localization possibility > 0

Next, 622 we assembled reads to transcripts and quantified the read counts of each genes utilizing StringTie 623 [64]. Lowly expressed genes were filtered out using a Counts per million (CPM) threshold. We 624 kept genes that CPM is greater than 1 in at least 2 samples and analyzed the differential expression

The DEGs were divided into 2 gene sets according to their expression change status (cluster 1 & 631 2 for upregulated genes and cluster 3 & 4 for downregulated genes) as represented in Figure 7A

Then, the putative transcription factor (TF)-targeting regulons of these 2 gene sets were identified 633 by employing RcisTarget [66]. We choose human motif collection v9 as TF annotation and the 634 motif-rankings in 10 kb around transcription start sites (TSS) of hg38 genome as region databases

The motifs with most target genes as well as a normalized enrichment score (NES) lager than 3

We performed alternative splicing (AS) analysis based on transcription raw reads with vast-tools

To determine significant AS events, we kept 641 the AS event which have more than 10 reads in at less two samples and applied a further filter by 642 setting a noB3 parameter to AltEx (alternative exons) and a 0

Significant AS events were defined according to 644 the following requirements: change was greater than 10 dPSI (delta Percent-Spliced-In) / dPIR 645 (delta Percent-Intron-Retention)

Gene ontology and gene set enrichment analysis 648 GO and GSEA were implemented based on clusterProfiler package. C2 (curated gene sets)

Significant terms were chosen by the threshold that 651 P value < 0.05, FDR < 0.25 and |NES| > 1. Most significant terms were selected to plot heatmap

Both GO and Reactome pathway enrichments were applied using the Over Representation

Analysis (ORA) based on the hypergeometric distribution and P value of each term was adjusted 654 by BH method. Gene ontology analysis of BP, Cellular Component (CC)

Conceptualization, Investigation, Validation, Visualization. Zhenhuan Feng: 670 Conceptualization, Formal analysis, Data Curation, Visualization. Xiaofei Zhang

Supervision, Writing -original draft, Writing -review & editing, Funding

Work 679 in Zhang lab is supported by the Guangdong Science and Technology Project (Grant Nos. 680 2018B030306047 and 2020B1212060052), National Natural Science Foundation (Grant Nos. 681 31770889 and 31801180

We thank all researchers whose excellent work helped us to understand 686 and tackle the COVID-19. We like to thank Prof Duanqing Pei from Westlake University, China, 687 for valuable suggestions. We like to thank all member in Zhang lab for fruitful discussions, Liman 688 Guo from Proteomics & Metabolomics Centre of Bioland Laboratory for excellent mass-689 spectrometry measurements assistance

A novel coronavirus from patients with 700 pneumonia in China

Crystal structure of SARS-CoV-2 702 papain-like protease

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The 704 species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and 705 naming it SARS-CoV-2

A new coronavirus associated with 707 human respiratory disease in China

Chinese Center for Disease 709 Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel 710 coronavirus diseases (COVID-19) in China

Genomic characterisation and epidemiology 713 of 2019 novel coronavirus: implications for virus origins and receptor binding

WHO declares COVID-19 a pandemic

Viral targets for vaccines against COVID-19

Therapeutics and vaccines: 720 strengthening our fight against the global pandemic COVID-19

The architecture of SARS-CoV-2 722 transcriptome

Genomic characterization of the 724 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after 725 visiting Wuhan

Severe acute respiratory 727 syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles

SARS-coronavirus replication is supported by a reticulovesicular network of modified 731 endoplasmic reticulum

+)RNA viruses rewire cellular pathways to build replication 733 organelles

Nsp3 of coronaviruses: structures and functions of a large 735 multi-domain protein

CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase

A noncovalent class 739 of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Papain-like 742 protease regulates SARS-CoV-2 viral spread and innate immunity

Mechanism 744 and inhibition of the papain-like protease, PLpro, of SARS-CoV-2

A putative role of de-mono-ADP-ribosylation of STAT1 by the SARS-CoV-2 746 Nsp3 protein in the cytokine storm syndrome of COVID-19

Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by 749 nanobodies

Interactomes of SARS-CoV-2 and 751 human coronaviruses reveal host factors potentially affecting pathogenesis

Comparative host interactomes of the SARS-CoV-2 754 nonstructural protein 3 and human coronavirus homologs

The papain-like protease 756 of severe acute respiratory syndrome coronavirus has deubiquitinating activity

Localization 759 of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late 760 endosomes in viral replication

Identification and characterization 762 of severe acute respiratory syndrome coronavirus replicase proteins

Mutation in murine coronavirus 764 replication protein nsp4 alters assembly of double membrane vesicles

Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation

A SARS-CoV-2 770 protein interaction map reveals targets for drug repurposing

The reactome pathway 772 knowledgebase

Rapid 774 immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin 775 complexes

The BioGRID 777 database: a comprehensive biomedical resource of curated protein, genetic, and chemical 778 interactions

Multilevel proteomics 780 reveals host perturbations by SARS-CoV-2 and SARS-CoV

High-throughput and high-sensitivity 782 phosphoproteomics with the EasyPhos platform

Actionable 784 cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2

The global 787 phosphorylation landscape of SARS-CoV-2 infection

KinMap: a web-based tool for interactive 789 navigation through human kinome data

Fostamatinib for the treatment of chronic immune thrombocytopenia

A high-content screen for mucin-1-reducing compounds identifies fostamatinib as a candidate 794 for rapid repurposing for acute lung injury

Specificity in ubiquitination triggered by virus infection

Broad and diverse mechanisms used by 798 deubiquitinase family members in regulating the type I interferon signaling pathway during 799 antiviral responses

Gene set 801 enrichment analysis: a knowledge-based approach for interpreting genome-wide expression 802 profiles

The Molecular 804 Signatures Database (MSigDB) hallmark gene set collection

p53 down-806 regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro 807 via E3 ubiquitin ligase RCHY1

Proteomics of SARS-809 CoV-2-infected host cells reveals therapy targets

Viral strategies for circumventing p53: the case of severe acute 811 respiratory syndrome coronavirus

Innate immunity during SARS-CoV-2: evasion strategies and 813 activation trigger hypoxia and vascular damage

SARS-CoV2 drives JAK1/2-815 dependent local and systemic complement hyper-activation

The potential of JAK/STAT pathway inhibition by ruxolitinib in the 817 treatment of COVID-19

JAK 819 inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce 820 morbidity and mortality

A systemic and molecular 822 study of subcellular localization of SARS-CoV-2 proteins

RNA-GPS predicts SARS-CoV-2 RNA 825 residency to host mitochondria and nucleolus

Fine-tuning BMP7 827 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6

An 830 interaction landscape of ubiquitin signaling

The MaxQuant computational platform for mass spectrometry-832 based shotgun proteomics

Proteome-wide 834 identification of ubiquitin interactions using UbIA-MS

Accurate protein complex retrieval by affinity enrichment 836 mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS)

ReactomeFIViz: a Cytoscape app for pathway 839 and network-based data analysis

clusterProfiler: an R package for comparing biological 841 themes among gene clusters

circlize Implements and enhances circular 843 visualization in R

The KSEA App: a web-based tool for kinase activity 845 inference from quantitative phosphoproteomics

GPS 5.0: an update on the prediction 847 of kinase-specific phosphorylation sites in proteins

Graph-based genome alignment and 850 genotyping with HISAT2 and HISAT-genotype

StringTie enables 852 improved reconstruction of a transcriptome from RNA-seq reads

edgeR: a Bioconductor package for differential 854 expression analysis of digital gene expression data

856 SCENIC: single-cell regulatory network inference and clustering

An 858 atlas of alternative splicing profiles and functional associations reveals new regulatory programs 859 and genes that simultaneously express multiple major isoforms

Schematic illustration of SARS-CoVs NSP3 proteins. Domain illustration of NSP3 proteins of

X / Mac1 is macrodomain I, Mac2 / Mac3 / DPUP are macrodomain II, III and 870 domain preceding Ubl2 and PLpro, Ubl2 is ubiquitin like domain 2, PLpro is Papain-like protease, 871 NAB / β SM is nucleic acid-binding and beta-coronavirus-specific marker domain, TM1 is 872 transmembrane region 1, 3Ecto is 3 ectodomain, TM2 is transmembrane region 2, AH1 is 873 amphipathic helix1, Y is a domain with unknown functions. B. GRL0617 inhibits the release of 874 EGFP from NSP3-EGFP protein. Cells transfected with indicated plasmids (Figure S1A) were 875 treated with DMSO or GRL0617 for 24 h. Cells were lysed and EGFP antibody was used for 876 immunoblotting. Green arrow indicates released EGFP protein, and asterisk indicates non-specific 877 signal. GAPDH was used to serve as a loading control. C. Schematic illustration of plasmids used 878 in Figure 1D. D. CoV2-NSP3 is processed at the N-terminus. Cells transfected with indicated 879 plasmids (Figure 1C) were analyzed as in Figure 1B. Green arrow indicates the released EGFP 880 and red arrow around 15 kDa indicates processed N-terminus of CoV2-NSP3. Asterisks indicate 881 non-specific signals

Flag and TOMM20 antibodies were used to visualize the co-localization

Severe Acute Respiratory Syndrome-Coronavirus

Nonstructural Protein 3; EGFP, 885 Enhanced Green Fluorescent Protein

DAPI, 4',6-diamidino-2-phenylindole

WT, wild type NSP3; CS, 887 catalytic inactivated NSP3; dGG, glygly deficient NSP3

Figure 2 N-terminal determines the extra processing and mitochondria localization of NSP3

Schematic illustration of chimeric plasmids used in Figure 2. B. The processing site of CoV2-891 NSP3 is localized at its N-terminus. HEK293T cells transfected with indicated plasmids were 892 analyzed as in Figure 1B

PLpro ex indicates the exchange of PLpro domain, whereas Ubl1+HVR ex indicates the exchange of 894 Ubl1 and HVR domains

Significant interactors of NSP3 were 900 analyzed to show the shared and unique interactions (Table S1). Data analysis as described in 901 material and methods

Indicated antibodies were used 909 to detect the interactions. Label Free Quantification (LFQ) intensity of each interactor was log2 910 transformed and then substrate its intensity identified in EGFP condition. Black asterisk indicates 911 non-specific signal, whereas green asterisk indicates leaked EGFP signal. D. Venn diagram 912 showing the overlap of CoV2-NSP3 interactors identified in our study and interactors obtained 913 from BioGrid and Almasy and his colleagues

The interactors of NSP3 922 proteins were combined with reported SARS-CoV-2 interactors to create viral protein-host protein 923 interaction network (Table S4). Interactors specific for CoV1-NSP3 and CoV2-NSP3 are 924 displayed as different colors. Cytoscape was used to create the connection map of NSP3, 925 interactors, and SARS-CoV-2 proteins as described in material and methods

Figure 5 Phosphoproteome analysis of NSP3-expressing cells

Clustering of DEPPs in NSP3-expressing cells. DEPPs show significantly differences in CoV1-929 NSP3-and CoV2-NSP3-expressing cells compared to control cells which were clustered together

Top panel: Schematic representation of phosphorylated sites of 933 indicated proteins. Square indicates DEPP has significant change in CoV1-NSP3-expressing cells, 934 whereas circle indicates DEPP has significant change in CoV2-NSP3-expressing cells. Analysis 935 and colors as in Figure 3A; Bottom panels: HEK293T cells transfected with indicated plasmids 936 were subjected to immunoprecipitation (Flag-resin or UBE2O antibody with protein A/G), 937 following immunoblotting with phosphorylated serine, threonine antibodies. ImageJ was used to 938 quantify the relative expression of each protein to its matching loading control. C. Representative 939 enriched BP and Reactome

Full list of the GO and Reactome terms is shown in Table S5. Bold terms containing DEPPs that 941 are highlighted in the right of Figure 5A. D. KinMaps show altered kinases whose activity mapped 942 to DEPPs in NSP3-expressing cells

CoV2-NSP3-expressing cells were matched to kinases. Kinome profiling was performed using

Size of the 945 circles reflects the number of DEPPs. DEPPs, differentially enriched phosphorylated peptides

Analysis and 951 colors as in Figure 3A. Full list of DEUPs is available in Table S6. B. BP and Reactome analyses 952 of catalytic activity dependent-and independent-DEUPs

Schematic representation of identified ubiquitination sites of NSP3 proteins. The 954 intensity of each ubiquitinated site was log2 transformed and compared between CS-and WT-955 mutated NSP3-expressing cells. Colors as in Figure 3A. D. Alignment of the Ubl1 and HVR 956 domains of NSP3 proteins

CoV1-NSP3. DEUPs, differentially enriched ubiquitinated peptides

Figure 7 Transcriptome and proteome analyses of NSP3-expressing cells

Motif enrichment analysis of DEGs in NSP3-expressing cells. DEGs show significantly 961 differences in NSP3-expressing cells which were clustered together. Analysis and colors as in

Enriched motifs are shown in the right of the 964 heatmap. Full list of the DEGs and enriched motifs related genes is available in Table S7. B. Gene 965 set enrichment analyses. C2 (curated gene sets) and C5 (GO gene sets) from MSigDbv7.2 and 966 pathway gene sets from Reactome pathway database were used for GSEA. NES represents 967 normalized enrichment score. Full list of the GO and GSEA is available in Table S7. C. Alternative 968 splicing events in NSP3-expressing cells. Schematic illustration of alternative splicing events 969 identified in NSP3 expressing cells (left panel). AS events was identified from the RNA-seq data 970 of NSP3-expressing cells

AltEX represents alternative exon, Alt5 and Alt3 represents alternative 5' and 3' UTR, and IR 972 represents intron retention. D. Clustering of DEPs in NSP3-expressing cells. Analysis and colors expression trend in both transcriptome and proteome data

GSEA, gene set enrichment analyses

Regulation of p53 and alternative splicing by NSP3. Multi-omics data were combined to 982 model the regulation of p53 (A) and alternative splicing (B) by NSP3. Network was created using

FI represents functional interaction. C. Candidate proteins for 984 drug repurposing. Candidate proteins that are regulated by NSP3 in at least two omics studies were 985 shown. The rectangular is divided into two triangles to indicate upregulated or downregulated 986 ubiquitination or phosphorylation events. Color as in Figure 3A

Schematic overview of NSP3 regulated cellular functions. Red indicates difference of two NSP3

Figure S1 Expression and subcellular localization of NSP3 proteins with C-terminal tag

NSP3 cleaves itself at 997 the C-terminus. HEK293T cells transfected with CoVs-NSP3-EGFP plasmids were lysed and 998 EGFP and NSP3 antibodies were used after immunoblotting. EGFP was released in WT, but not 999 in CS-or dGG-mutated NSP3 samples. Green arrow indicates the released EGFP, whereas asterisk 1000 indicates non-specific signal. C. Validation of the specificity of CoV-1 NSP3 antibody

Red arrow indicates that the 1009 large vesicle-like structure of CoV2-NSP3 was not co-localized with TOMM20. C. CoV2-NSP3 1010 has two cellular localizations. Immunostaining was performed as in Figure S2A. Merged signals 1011 show that GFP and NSP3, but not NSP3 and Flag, are co-localized well. D. Flag-CoV1-NSP3 1012 prefers to co-localize with CANX. Immunostaining was performed as in Figure S2A. Flag and 1013 CANX antibodies were used to visualize the co-localization between CoV1-NSP3 and the ER 1014 marker CANX. E. Interaction preference of NSP3 protein and CANX/TOMM20

Figure S3 PLpro domain of CoV1-NSP3 is responsible for the formation of the large vesicle-1020 like structures

CoV2-NSP3 fused with PLpro domain of CoV1-NSP3 induces large-vesicle structures

Figure S4 Workflow and quality control of multi-omics study

Schematic overview of the workflow to study the function of NSP3. B. Boxplots of log2 1026 imputed intensity for all proteomics studies. FASP, Filter Aided Sample Preparation

Figure S5 Protein-protein interaction network of NSP3 interactomes

Top 1000 variable proteins 1031 with highest standard deviation (Table S1) were used as input for PCA analysis. B. Upset and 1032 Venn diagrams showing the overlap of NSP3 interactors. Significant interactors for WT and CS 1033 of NSP3 proteins were used as input

Protein-protein interaction network of CoV2-NSP3 (C) and CoV1-NSP3 (D) interactomes

Significant interactors of NSP3 were clustered by gene annotation and protein-protein interaction 1036 network was constructed using Cytoscape with ReactomeFI v7.2.3. PCA, principal component 1037 analysis

Figure S6 Crosslinking IP-MS to identify NSP3 interactome

PCA analysis of top 1000 variable proteins of NSP3 interactomes. Top 1000 variable proteins 1041 of each condition (Table S2) were used as input for PCA analysis. B. Venn diagram showing the 1042 overlap of NSP3 interactors identified in crosslinking and non-crosslinking experiments

Clustering of significant interactors of NSP3 proteins using crosslinking IP-MS. Analysis and 1044 color as Figure 3A. Full list of interactors is available in Table S2. D. Representative enriched GO 1045 of identified interactors in crosslinking IP-MS. Analysis as Figure 3B

Figure S7 NSP3 interactome identified by EGFP IP-MS

PCA analysis of top 1000 variable proteins of NSP3-EGFP interactomes. Top 1000 variable 1050 proteins with highest standard deviation (Table S3) were used as input for PCA analysis

Clustering of significant interactors of NSP3 proteins

Analysis as 1055 Figure 3B. Full list of GO terms is available in Table S3

Figure S8 Phosphoproteome related analyses

Top 1000 1059 variable phosphorylated peptides with standard deviation (Table S5) were used as input for PCA 1060 analysis. B. Clustering of DEPPs which were also found in SARS-CoV-2 infection studies. Two 1061 reported phosphoproteome data were used as inputs to identify consistent phosphorylated peptides

Analysis and color as Figure 3A. Full list of DEPPs is available in Table S5. C. Cell cycle analysis 1063 of NSP3 expressing cells. Cells transfected with indicated plasmids were harvest for FACS 1064 analysis using propidium iodide. Significant differences compared to control cells were calculated 1065 using Student's t-tests. The graph showed mean ± SD

One representative experiment was shown. D. and E. Kinases inhibitors mapped to kinases 1067 whose activity mapped to DEPPs in CoV2-NSP3 (D) and CoV1-NSP3 (E) expressing cells. Red 1068 indicates upregulated activity, whereas blue indicates downregulated activity. F. Clustering of 1069 DEPPs that regulated by IKK-family and TBK1

Top 1000 1075 variable ubiquitinated peptides with highest standard deviation (Table S6) were used as input for 1076 PCA analysis. B. Deubiquitinase activity dependent ubiquitylome of NSP3 protein. Analysis and 1077 color as in Figure 3A

Figure S10 Regulation of innate response by NSP3

Multi-omics data were combined to model the regulation innate response by NSP3. Network was 1081 created using Cytoscape with ReactomeFI

Table S1 NSP3 interactome identified by Flag IP-MS

Table S2 NSP3 interactome identified by crosslinking Flag IP-MS

Table S3 NSP3 interactome identified by EGFP IP-MS

Table S4 Host proteins interact with NSP3 and other SARS-CoV-2 proteins

Conceptualization, Investigation, Validation, Visualization. Zhenhuan Feng: 1094 Conceptualization, Formal analysis, Data Curation, Visualization. Xiaofei Zhang

Supervision, Writing -original draft, Writing -review & editing, Funding 1096 acquisition. All authors read and approved the final manuscript